CA 19-9 as a predictor of response and survival in patients with pancreatic cancer treated with gemcitabine and cisplatin based chemotherapy

被引：0
|
作者：
Heilbrun, L. K.
Khanna, A.
Venkatramanamoorthy, R.
Shields, A. F.
Philip, P. A.
Zalupski, M. M.
El-Rayes, B. F.
机构：
[1] Karmanos Canc Inst, Detroit, MI USA
[2] Wayne State Univ, Detroit, MI USA
[3] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15094
引用
收藏
页数：4
相关论文
共 50 条
  • [1] CA 19-9 as a predictor of response and survival in patients with pancreatic cancer treated with gemcitabine and cisplatin based chemotherapy.
    Patel, B
    Heilburn, L
    Khanna, A
    Venkatramanamoorthy, R
    Shields, A
    Philip, P
    Zalupski, M
    El-Rayes, B
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 355S - 355S
  • [2] CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy
    Hammad, Nazik
    Heilbrun, Lance K.
    Philip, Philip A.
    Shields, Anthony F.
    Zalupski, Mark M.
    Venkatramanamoorthy, Raghu
    El-Rayes, Bassel F.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2010, 6 (02) : 98 - 105
  • [3] CA 19-9 AS A PREDICTOR FOR RESPONSE AND SURVIVAL IN ADVANCED PANCREATIC CANCER PATIENTS TREATED WITH CHEMORADIOTHERAPY
    Koom, Woong Sub
    Seong, Jinsil
    Kim, Yong Bae
    Pyun, Hae Ok
    Song, Si Young
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (04): : 1148 - 1154
  • [4] CA 19-9 as a predictor for the response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy
    Koom, W.
    Seong, J.
    Kim, Y.
    Pyun, H.
    Song, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S261 - S262
  • [5] Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin?
    Stemmler, J
    Stieber, P
    Szymala, AM
    Schalhorn, A
    Schermuly, MM
    Wilkowski, R
    Helmberger, T
    Lamerz, R
    Stoffregen, C
    Niebler, K
    Garbrecht, M
    Heinemann, V
    ONKOLOGIE, 2003, 26 (05): : 462 - 467
  • [6] Prognostic value of CA 19-9 in patients with pancreatic cancer treated with Gemcitabine
    Halm, U
    Schuhmann, T
    Keim, V
    Moessner, J
    GASTROENTEROLOGY, 1999, 116 (04) : A1129 - A1129
  • [7] Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer
    Halm U.
    Schumann T.
    Schiefke I.
    Witzigmann H.
    Mössner J.
    Keim V.
    British Journal of Cancer, 2000, 82 (5) : 1013 - 1016
  • [8] Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer
    Halm, U
    Schumann, T
    Schiefke, I
    Witzigmann, H
    Mössner, J
    Keim, V
    BRITISH JOURNAL OF CANCER, 2000, 82 (05) : 1013 - 1016
  • [9] CA19-9:: A pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin
    Heinemann, V
    Schermuly, MM
    Stieber, P
    Schulz, L
    Jüngst, D
    Wilkowski, R
    Schalhorn, A
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2433 - 2435
  • [10] CA 19-9 response as an early indicator of the effectiveness of gemcitabine in patients with advanced pancreatic cancer
    Nakai, Yousuke
    Kawabe, Takao
    Isayama, Hiroyuki
    Sasaki, Takashi
    Yagioka, Hiroshi
    Yashima, Yoko
    Kogure, Hirofumi
    Arizumi, Toshihiko
    Togawa, Osamu
    Ito, Yukiko
    Matsubara, Saburo
    Hirano, Kenji
    Sasahira, Naoki
    Tsujino, Takeshi
    Tada, Minoru
    Omata, Masao
    ONCOLOGY, 2008, 75 (1-2) : 120 - 126
12345